Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Description

This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.

Conditions

Human Papillomavirus Infection

Talk to us

Study Overview

On this page

Study Details

Study overview

This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.

Implementation of Evidence-Based Strategies to Optimize HPV Vaccination in Rural Primary Care Settings

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Condition
Human Papillomavirus Infection
Intervention / Treatment

-

Contacts and Locations

Buffalo

Roswell Park Cancer Institute, Buffalo, New York, United States, 14263

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * PRACTICES: Are located in the 20-county target region
  • * PRACTICES: Have an adolescent patient population \>= 150 (aged 9-18)
  • * PRACTICES: Administer adolescent vaccines (e.g., HPV, Tdap, MCV4)
  • * PRACTICES: Are willing to share aggregate practice and patient-level data (e.g., electronic health record \[EHR\], surveys)
  • * PARTICIPANTS: Medical providers and medical staff \>= 18 years of age
  • * PARTICIPANTS: Primary care providers and medical office staff who deliver adolescent care at community-based primary care practice sites across 20 rural counties in central and western New York
  • * PARTICIPANTS: Age \>= 18 years of age (no upper limit)
  • * PARTICIPANTS: English speaking
  • * PARENT/GUARDIAN SURVEY: Adult accompanying a child or children aged 9 to 17
  • * PARENT/GUARDIAN SURVEY: English speaking
  • * PARENT/GUARDIAN SURVEY: Presenting to the participating clinic for an outpatient well child visit or regular checkup
  • * PARENT/GUARDIAN SURVEY: Willing to complete an anonymous survey while visiting the clinic
  • * Unwilling or unable to follow protocol requirements
  • * Adults unable to complete study measures in English
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Cognitively impaired adults/adults with impaired decision-making capacity
  • * Prisoners

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Roswell Park Cancer Institute,

Elisa Rodriguez, PRINCIPAL_INVESTIGATOR, Roswell Park Cancer Institute

Study Record Dates

2028-04-30